$102.37
-0.85%Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products worldwide. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The Personal Care segment offers disposable diapers, swimpants, training and youth pants, baby wipes, feminine and incontinence care products, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Depend, Plenitud, Softex, Poise, and other brand names. The Consumer Tissue segment provides facial and bathroom tissues, paper towels, napkins, and related products under the Kleenex, Scott, Cottonelle, Viva, Andrex, Scottex, Neve, and other brand names. The K-C Professional segment offers wipers, tissues, towels, apparel, soaps, and sanitizers under the Kleenex, Scott, WypAll, Kimtech, and KleenGuard brands. The company sells household use products directly to supermarkets, mass merchandisers, drugstores, warehouse clubs, variety and department stores, and other retail outlets, as well as through other distributors and e-commerce; and away-from-home use products directly to manufacturing, lodging, office building, food service, and public facilities, as well as through distributors and e-commerce. Kimberly-Clark Corporation was founded in 1872 and is headquartered in Dallas, Texas.
Chairman & Chief Executive Officer
Compensation
$5,413,017
Chief Digital & Technology Officer
Compensation
$2,535,194
Chief Human Resources Officer
Chief Strategy, Business Development & Administrative Officer
Compensation
$2,338,016
Head Corporate Communications & Government Affairs - India
Interim Chief Human Resources Officer
Investor Relations Contact
President & Chief Operating Officer
Compensation
$1,959,404
Senior Vice President & Chief Financial Officer
Compensation
$2,238,306
Senior Vice President & Chief People Officer
Compensation
$968,829
Senior Vice President, General Counsel & Corporate Secretary
Vice President and MD of India & South Asia
During the last 12 months, insiders have sold $2.01M worth of KMB shares, with no buying activity reported.
0
0.00
0
0.00
+0
+$0
0
0.00
0
0.00
+0
+$0
0
0.00
0
0.00
+0
+$0
0
0.00
15.0K
2.01M
-2.0M
-$2.01M
No buying activity
Hicks Zackery A
Officer: Chief Digital & Technology Off
$2.01M
Strong bearish signal with $2.01M net selling. Heavy insider selling may indicate concerns about valuation or near-term prospects.
Very poor ratio. Heavy selling with minimal buying suggests insiders may be concerned about valuation or outlook.
1 insider sellers vs. 0 buyers. Widespread selling across multiple insiders may signal concerns.
KMB - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
DEF 14A DEF 14A 2025 N/A | March 23, 2026 | December 31, 2025 | 2025 | |
DEF 14A DEF 14A 2024 N/A | March 10, 2025 | December 31, 2024 | 2024 | |
DEF 14A DEF 14A 2024 N/A | March 11, 2024 | March 11, 2024 | 2024 | |
DEF 14A DEF 14A N/A | February 27, 2023 | February 27, 2023 | ||
DEF 14A DEF 14A 2022 N/A | March 07, 2022 | April 27, 2022 | 2022 | |
DEF 14A DEF 14A 2021 N/A | March 08, 2021 | April 29, 2021 | 2021 | |
DEF 14A DEF 14A 2020 N/A | March 06, 2020 | April 29, 2020 | 2020 | |
DEF 14A DEF 14A 2019 N/A | March 08, 2019 | May 02, 2019 | 2019 | |
DEF 14A DEF 14A 2018 N/A | March 16, 2018 | May 10, 2018 | 2018 | |
DEF 14A DEF 14A 2017 N/A | February 27, 2017 | April 20, 2017 | 2017 |
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.